Total Payments
$2,216
2024 Payments
$555.91
Companies
23
Transactions
94
Medicare Patients
12,639
Medicare Billing
$1.4M
Payment Breakdown by Category
Food & Beverage$2,216 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,216 | 94 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $236.63 | 13 | $0 (2024) |
| ShockWave Medical, Inc | $191.26 | 1 | $0 (2024) |
| PFIZER INC. | $189.54 | 7 | $0 (2024) |
| Amgen Inc. | $180.58 | 10 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $161.98 | 9 | $0 (2022) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $161.12 | 10 | $0 (2024) |
| Abbott Laboratories | $141.08 | 4 | $0 (2019) |
| Merck Sharp & Dohme LLC | $134.74 | 7 | $0 (2023) |
| Cardiovascular Systems Inc. | $132.89 | 4 | $0 (2021) |
| Baxter Healthcare | $131.01 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $555.91 | 17 | ShockWave Medical, Inc ($191.26) |
| 2023 | $446.56 | 21 | Merck Sharp & Dohme LLC ($74.73) |
| 2022 | $294.78 | 16 | Novartis Pharmaceuticals Corporation ($74.14) |
| 2021 | $176.57 | 8 | Cardiovascular Systems Inc. ($65.99) |
| 2020 | $177.41 | 8 | PFIZER INC. ($43.87) |
| 2019 | $125.34 | 8 | AstraZeneca Pharmaceuticals LP ($39.86) |
| 2018 | $281.15 | 8 | Abbott Laboratories ($113.35) |
| 2017 | $158.74 | 8 | Cardiovascular Systems Inc. ($55.52) |
All Payment Transactions
94 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $21.78 | General |
| 10/31/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/24/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.38 | General |
| Category: Cardiovascular | ||||||
| 10/17/2024 | Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $63.60 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 09/26/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Cardiology | ||||||
| 09/12/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $24.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/04/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: IMMUNOLOGY | ||||||
| 08/08/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Cardiology | ||||||
| 08/01/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/24/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/09/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $27.91 | General |
| Category: Cardiology | ||||||
| 05/02/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/01/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $191.26 | General |
| Category: Lithoplasty | ||||||
| 04/18/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: Cardiology | ||||||
| 03/01/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/25/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: Cardiology | ||||||
| 12/13/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $31.93 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 11/17/2023 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $26.87 | General |
| Category: Cardiology | ||||||
| 11/02/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/26/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/19/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Cardiology | ||||||
| 10/12/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/05/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/07/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 3,781 | 5,224 | $1.5M | $391,974 |
| 2022 | 24 | 2,855 | 3,900 | $1.3M | $316,655 |
| 2021 | 30 | 3,371 | 4,813 | $1.5M | $396,391 |
| 2020 | 25 | 2,632 | 3,920 | $1.2M | $314,881 |
Total Patients
12,639
Total Services
17,857
Medicare Billing
$1.4M
Procedure Codes
118
All Medicare Procedures & Services
118 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 251 | 252 | $364,320 | $84,091 | 23.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 332 | 341 | $188,232 | $47,959 | 25.5% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 250 | 502 | $136,406 | $45,179 | 33.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 234 | 328 | $73,013 | $31,419 | 43.0% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 158 | 645 | $97,602 | $28,311 | 29.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 302 | 447 | $76,660 | $28,240 | 36.8% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 118 | 120 | $66,079 | $17,052 | 25.8% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 284 | 290 | $80,944 | $13,975 | 17.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 100 | 107 | $49,735 | $13,841 | 27.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 84 | 84 | $43,296 | $13,240 | 30.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 71 | 123 | $32,404 | $11,206 | 34.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 72 | 129 | $26,742 | $7,896 | 29.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 1,006 | 1,305 | $72,588 | $7,821 | 10.8% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 35 | 35 | $64,981 | $6,878 | 10.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 62 | 62 | $26,762 | $6,810 | 25.4% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 40 | 43 | $25,535 | $5,371 | 21.0% |
| 93924 | Ultrasound of leg arteries at rest and after exercise | Office | 2023 | 46 | 51 | $23,740 | $5,205 | 21.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 80 | 80 | $25,302 | $4,374 | 17.3% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 19 | 22 | $13,598 | $3,852 | 28.3% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 12 | 12 | $26,952 | $3,100 | 11.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 12 | 15 | $9,630 | $2,442 | 25.4% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 14 | 15 | $2,118 | $923.11 | 43.6% |
| 93571 | Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | Facility | 2023 | 16 | 16 | $8,072 | $876.48 | 10.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 59 | 67 | $4,832 | $736.57 | 15.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 61 | 66 | $1,574 | $347.05 | 22.0% |
About Dr. Ather Anis, M.D
Dr. Ather Anis, M.D is a Interventional Cardiology healthcare provider based in Winchester, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/28/2007. The National Provider Identifier (NPI) number assigned to this provider is 1184770349.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ather Anis, M.D has received a total of $2,216 in payments from pharmaceutical and medical device companies, with $555.91 received in 2024. These payments were reported across 94 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($2,216).
As a Medicare-enrolled provider, Anis has provided services to 12,639 Medicare beneficiaries, totaling 17,857 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 118 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Cardiovascular Disease, Internal Medicine
- Location Winchester, VA
- Active Since 01/28/2007
- Last Updated 01/02/2026
- Taxonomy Code 207RI0011X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1184770349
Products in Payments
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) $191.26
- LifeVest (Device) $161.12
- ELIQUIS (Drug) $138.33
- VERQUVO (Drug) $134.74
- XARELTO (Drug) $130.79
- Repatha (Biological) $126.48
- ENTRESTO (Drug) $124.95
- LEQVIO (Drug) $111.68
- OPSUMIT (Drug) $99.12
- Mitra Clip system (Device) $95.81
- CHANTIX (Drug) $80.10
- BRILINTA (Drug) $75.98
- Hillrom - Cardiac Ambulatory Monitor (Device) $67.41
- Peripheral Orbital Atherectomy System (Device) $66.90
- Diamondback Coronary (Device) $65.99
- Hillrom - Carnation Ambulatory Monitor (Device) $63.60
- Corlanor (Drug) $54.10
- FARXIGA (Drug) $53.45
- (7999) SRC Undivided (Device) $37.19
- Inpefa (Drug) $31.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Winchester
Daniel Reese, Md, MD
Interventional Cardiology — Payments: $10,030
Interventional Cardiology $10,030
Dr. Neal Gaither, Md, MD
Interventional Cardiology — Payments: $8,969
Interventional Cardiology $8,969
Randolph Renzi, Md, MD
Interventional Cardiology — Payments: $5,555
Interventional Cardiology $5,555
Sumeet Lall
Interventional Cardiology — Payments: $5,218
Interventional Cardiology $5,218